Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
$BTC: Peter Schiff Calls Bitcoin Trading Above $21K a “Sucker’s Rally”
-
Growing Customer Demand For Definitive Healthcare’s SaaS Platform
-
Dorsey Challenges Cook: 'Why No Bitcoin in Apple Pay?'
-
Hopes Of A Spot Bitcoin ETF Dashed As SEC Again Extends ARK Deadline To January
-
BTC Bulls Are Back? On-chain Indicators Point to Short-Term Rally